On November 9, 2021 Aadi Bioscience, Inc. ("Aadi"), clinical-stage biopharmaceutical company focusing on precision therapies for genetically-defined cancers with alterations in mTOR pathway genes, reported that management will be participating in the upcoming Jefferies London Healthcare Conference and the Piper Sandler Virtual Healthcare Conference (Press release, Aadi Bioscience, NOV 9, 2021, View Source [SID1234594886]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Conference details can be found below.

Jefferies London Healthcare Conference
Format: Pre-recorded presentation and one-on-one investor meetings
Presentation accessible on demand starting: Thursday, November 18 3:00 am ET / 12:00 am PT
Webcast link: View Source

A live webcast of this presentation will also be accessible in the Events & Presentations section of the company’s website at View Source Replay will also be available at this link for 90 days.

Piper Sandler Virtual Healthcare Conference
Format: Pre-recorded presentation and one-on-one investor meetings
Presentation accessible on demand for conference registrants starting: Monday, November 22 10:00 am ET / 7:00 am PT